A well characterized mechanism that leads to systemic endothelial dysfunction in the metabolic syndrome is insulin resistance, since insulin triggers AKT-dependent endothelial nitric oxide synthase (eNOS) phosphorylation, which mediates endothelial NO synthesis and release [43]. This evidence concerns the gene NOS3 and metabolic syndrome.